pentadecapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
=== Symmetry breaking === Theories for the origin of homochirality in the molecules of life can be classified as deterministic or based on chance depending on their proposed mechanism. If there is a relationship between cause and effect – that is, a specific chiral field or influence causing the mirror symmetry breaking – the theory is classified as deterministic; otherwise it is classified as a theory based on chance (in the sense of randomness) mechanisms.
== Description == Typical Catostylus with chunky appendages and tentacle to go with each. This jellyfish has a sting that causes light pain and a skin rash, but generally poses no serious threat. It is up to 65 cm (26 in) in bell diameter, but a more typical size is 25 cm (10 in) in diameter and 2.5 kg (5.5 lb) in weight. Its colour is variable and can be blue-white, cream, brown, or off-white. The exumbrellar grooves are reddish or purplish brown. C. tagi has gonads along the edge of its stomach in an X shape. It has the octant formation typical of Catostylus jellies, the height of the octants are also variable.
=== Serotonin syndrome === The development of a potentially life-threatening serotonin syndrome (also classified as "serotonin toxicity") may occur with venlafaxine treatment, particularly with concomitant use of serotonergic drugs, including but not limited to SSRIs and SNRIs, many hallucinogens such as tryptamines and phenethylamines (e.g., LSD/LSA, DMT, MDMA, mescaline), dextromethorphan (DXM), tramadol, tapentadol, pethidine (meperidine) and triptans and with drugs that impair metabolism of serotonin (including MAOIs). Serotonin syndrome symptoms may include mental status changes (e.g. agitation, hallucinations, coma), autonomic instability (e.g. tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g. hyperreflexia, incoordination), or gastrointestinal symptoms (e.g. nausea, vomiting, diarrhea). Venlafaxine-induced serotonin syndrome has also been reported when venlafaxine has been taken in isolation in overdose. An abortive serotonin syndrome state, in which some but not all of the symptoms of the full serotonin syndrome are present, has been reported with venlafaxine at mid-range dosages (150 mg per day). A case of a patient with serotonin syndrome induced by low-dose venlafaxine (37.5 mg per day) has also been reported.
Sources: en.wikipedia.org
The clinical course is determined by an immunological interplay between two types of T cells (Th1 and Th2 responses). SCD is often considered a subset of SNAS, but with only skin manifestations. SNAS presents with an array of symptoms ranging from respiratory to generalized skin rash to gastrointestinal symptoms. The gastrointestinal symptoms may mimic those of irritable bowel syndrome. A meta review evaluating SNAS found that 1% of patients sensitized to nickel reacted to the nickel content of a 'normal' diet, and with increasing doses of nickel more individuals reacted. SNAS is a multilayered immunological response demonstrating variance between individuals and doses of nickel exposure.
Determining a mechanism of action at the interface of the materials and biology is important if these novel clinical results have shown impact to the resolution of sleep apnea downstream. It can then be applied to all forms of dental devices and protocols. In the end, 'The development of an OSA treatment that is simple, affordable, comfortable, noninvasive, effective at all severity levels, and accepted by most patients is still the holy grail of sleep medicine'.
Nandrolone, also known as 19-nortestosterone, is an endogenous androgen. It is also an anabolic steroid (AAS) which is medically used in the form of esters such as nandrolone decanoate (brand name Deca-Durabolin) and nandrolone phenylpropionate (brand name Durabolin). Nandrolone esters are used in the treatment of anemias, cachexia (muscle wasting syndrome), osteoporosis, breast cancer, and for other indications. They are now used by oral administration or instead are given by injection into muscle or fat. Side effects of nandrolone esters include symptoms of masculinization like acne, increased hair growth, and voice changes. They are synthetic androgens and anabolic steroids and hence are agonists of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). Nandrolone has strong anabolic effects and weak androgenic effects, which give them a mild side effect profile and make them especially suitable for use in women and children. There are metabolites of Nandrolone that act as long-lasting prodrugs in the body, such as 5α-Dihydronandrolone. Nandrolone esters were first described and introduced for medical use in the late 1950s. They are among the most widely used anabolic steroid worldwide. In addition to their medical use, nandrolone esters are used to improve physique and performance, and are said to be the most widely used anabolic steroid for such purposes. The drugs are controlled substances in many countries and so non-medical use is generally illicit.
Sources: en.wikipedia.org
The astringency in tea can be attributed to the presence of polyphenols. These are the most abundant compounds in tea leaves, making up 30–40% of their composition. Polyphenols in tea include flavonoids, epigallocatechin gallate, and other catechins.
The Indian strain of K. pneumoniae had an OXA-181-encoding plasmid (which had higher resistance to carbapenem) and also could not be transferred by conjugation and had none of the three functional genes found in pOXA-48a.
The Napoleonic Wars (1803–1815) were a global series of conflicts fought by a fluctuating array of European coalitions against the French First Republic (1803–1804) under the First Consul followed by the First French Empire (1804–1815) under the Emperor of the French, Napoleon. The wars originated in political forces arising from the French Revolution (1789–1799) and French Revolutionary Wars (1792–1802) and produced a period of French domination over continental Europe. The wars are categorised as seven conflicts, five named after the coalitions that fought Napoleon, plus two named for their respective theatres: the War of the Third Coalition, War of the Fourth Coalition, War of the Fifth Coalition, War of the Sixth Coalition, War of the Seventh Coalition, the Peninsular War, and the French invasion of Russia. The first stage of the wars broke out when Britain declared war on France on 18 May 1803. After minor campaigns, Britain allied with Austria, Russia, and minor powers, to form the Third Coalition in April 1805. Napoleon defeated the allied Russo-Austrian armies in the subsequent war which climaxed in French victories at Ulm and at Austerlitz, leading to the dissolution of the Holy Roman Empire and Austria being forced to make peace. Britain and Russia remained at war with France. Concerned about increasing French power, Prussia joined Britain and Russia in the Fourth Coalition, which resumed war in October 1806.
=== MeSH D12.644.456 – oligopeptides === MeSH D12.644.456.050 – amanitins MeSH D12.644.456.073 – angiotensins MeSH D12.644.456.073.021 – angiotensin i MeSH D12.644.456.073.041 – angiotensin ii MeSH D12.644.456.073.041.050 – angiotensin amide MeSH D12.644.456.073.041.800 – saralasin MeSH D12.644.456.073.041.815 – 1-sarcosine-8-isoleucine angiotensin ii MeSH D12.644.456.073.055 – angiotensin iii MeSH D12.644.456.073.070 – angiotensinogen MeSH D12.644.456.120 – antipain MeSH D12.644.456.193 – bradykinin MeSH D12.644.456.193.400 – kallidin MeSH D12.644.456.241 – caerulein MeSH D12.644.456.270 – chalones MeSH D12.644.456.300 – delta sleep-inducing peptide MeSH D12.644.456.345 – dipeptides MeSH D12.644.456.345.159 – anserine MeSH D12.644.456.345.190 – aspartame MeSH D12.644.456.345.331 – carnosine MeSH D12.644.456.345.360 – enalapril MeSH D12.644.456.345.360.300 – enalaprilat MeSH D12.644.456.345.575 – glycylglycine MeSH D12.644.456.345.600 – lisinopril MeSH D12.644.456.400 – n-formylmethionine leucyl-phenylalanine MeSH D12.644.456.448 – glutathione MeSH D12.644.456.448.500 – glutathione disulfide MeSH D12.644.456.448.750 – s-nitrosoglutathione MeSH D12.644.456.460 – gonadorelin MeSH D12.644.456.460.150 – buserelin MeSH D12.644.456.460.315 – goserelin MeSH D12.644.456.460.480 – leuprolide MeSH D12.644.456.460.600 – nafarelin MeSH D12.644.456.460.800 – triptorelin MeSH D12.644.456.580 – leupeptins MeSH D12.644.456.650 – netropsin MeSH D12.644.456.716 – pentagastrin MeSH D12.644.456.724 – pepstatins MeSH D12.644.456.726 – peptichemio MeSH D12.644.456.729 – peptide t MeSH D12.644.456.735 – phalloidine MeSH D12.644.456.745 – thyrotropin-releasing hormone MeSH D12.644.456.800 – tachykinins MeSH D12.644.456.800.354 – eledoisin MeSH D12.644.456.800.475 – kassinin MeSH D12.644.456.800.500 – neurokinin a MeSH D12.644.456.800.550 – neurokinin b MeSH D12.644.456.800.745 – physalaemin MeSH D12.644.456.800.866 – substance p MeSH D12.644.456.805 – technetium tc 99m mertiatide MeSH D12.644.456.810 – teprotide MeSH D12.644.456.830 – tetragastrin MeSH D12.644.456.835 – thymic factor, circulating MeSH D12.644.456.840 – tuftsin MeSH D12.644.456.925 – vasopressins MeSH D12.644.456.925.100 – argipressin MeSH D12.644.456.925.100.250 – deamino arginine vasopressin MeSH D12.644.456.925.325 – felypressin MeSH D12.644.456.925.480 – lypressin MeSH D12.644.456.925.700 – ornipressin MeSH D12.644.456.925.730 – oxytocin MeSH D12.644.456.925.940 – vasotocin
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
Reversed-phase HPLC separates the sample into peaks, and the main peak is expressed as a percentage of total peak area. Mass spectrometry is then used to confirm that the molecular mass matches the expected value.